CBARP

Across TCGA pan-cancer cohorts, CBARP Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated CBARP data layer compared with 23 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CBARP Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CBARP expression acts as an unfavorable survival marker.

LUAD, LUSC, and LIHC are the cancer types where CBARP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.408	0.792	<.001	15	view →
LUSC	OS	Median	All	0.161	0.724	.008	9	view →
LIHC	OS	Median	All	0.105	0.774	.002	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

CBARP–LUAD (DFS)

Open the LUAD breakdown →